How Tandem Mass Spectrometry Sequences a Peptide: b/y Ions and the ABC-XYZ System
How tandem mass spectrometry reads a peptide sequence: fragment ion nomenclature, b and y ions, CID and the database search that turns spectra into sequences.
A certificate of analysis for a research peptide usually reports a mass and a purity figure. But how does a laboratory confirm that the molecule actually has the intended amino acid sequence, and not a deletion, a substitution or a scrambled order? The reference method is tandem mass spectrometry, often written MS/MS. This guide explains, in plain terms, how MS/MS reads a sequence off a peptide, what the fragment ion letters mean, and how software turns a spectrum into a sequence. It is written for laboratory researchers.
One mass is not enough
A single accurate mass tells you the total composition, but many different sequences share the same mass. Swap two residues and the mass is unchanged. Replace one amino acid with a combination that weighs the same and the mass is again unchanged. So a mass measurement alone cannot prove sequence. To read the order of residues you have to break the peptide apart in a controlled way and measure the pieces. That is what the second stage of tandem mass spectrometry does.
The basic idea of tandem MS
In a tandem experiment the instrument first selects a single peptide ion by its mass-to-charge ratio. That selected ion is called the precursor. The instrument then adds energy to it, usually by collision with an inert gas, a process called collision-induced dissociation (CID). The peptide breaks mostly along the backbone, producing a ladder of fragments. The second stage of the instrument measures the masses of those fragments. Because the peptide tends to break at the amide bonds between residues, the mass gaps between neighbouring fragments correspond to individual amino acids, and reading those gaps reconstructs the sequence.
The feasibility of sequencing peptides this way was established in the 1980s. Hunt and colleagues demonstrated protein sequencing by tandem mass spectrometry in the Proceedings of the National Academy of Sciences in 1986, a landmark that showed the backbone fragmentation pattern could be read as sequence.
The letters: a, b, c and x, y, z
The fragment ions have a standard naming system that confuses newcomers but is actually simple once the logic is clear. When the backbone breaks, the charge can stay on either side of the break. Which side keeps the charge, and exactly which bond broke, determines the letter.
- Fragments that keep the charge on the N-terminal (front) part of the peptide are called a, b and c ions.
- Fragments that keep the charge on the C-terminal (back) part are called x, y and z ions.
Within each group the specific letter depends on which of the three backbone bonds was cleaved. The b and y ions are by far the most common in ordinary collision-induced dissociation, which is why most tutorials focus on them. A matched series of b ions read from one end and y ions read from the other lets you assemble the full sequence and cross-check it.
This nomenclature was formalised by Roepstorff and Fohlman, who proposed the scheme in Biomedical Mass Spectrometry in 1984, and it was refined by Biemann, whose work on the contributions of mass spectrometry to peptide and protein structure appeared in Biomedical and Environmental Mass Spectrometry in 1988. A very readable modern summary is Steen and Mann's review, "The ABC's (and XYZ's) of peptide sequencing," in Nature Reviews Molecular Cell Biology in 2004.
Why peptides break where they do
The pattern of b and y ions is not random. The widely cited explanation is the mobile proton model, which holds that a proton added during ionisation can move along the peptide backbone and promote cleavage at particular amide bonds depending on where it sits and which residues are nearby. Residues such as proline and aspartic acid produce characteristic, often dominant, cleavages that experienced analysts learn to recognise. Understanding these preferences is what lets a researcher tell a real sequence match from a coincidence.
Reading a spectrum by hand, and why software does it
In principle you can read a short peptide by hand: line up the fragment masses, measure the gaps, and match each gap to the residue mass of an amino acid. In practice, peptides are measured by the thousands, and manual reading does not scale. Two amino acids, leucine and isoleucine, have identical masses and cannot be distinguished by ordinary CID at all, which is one of the method's well-known limitations.
The practical breakthrough was software that compares an observed spectrum against the predicted fragments of every candidate sequence in a database. Eng, McCormack and Yates described this approach, which became the SEQUEST algorithm, in the Journal of the American Society for Mass Spectrometry in 1994. Database searching is what made high-throughput sequencing possible, and the same principle underlies the tools used today to confirm that a synthetic peptide matches its intended sequence.
What this means for a research peptide COA
For quality control, tandem MS does something that a purity number alone cannot: it confirms identity at the sequence level. A peptide can be highly pure by HPLC and still be the wrong molecule if a residue was deleted or substituted during synthesis. MS/MS catches those errors by showing that the fragment ladder matches the intended sequence. It complements, rather than replaces, the purity and net-content figures discussed in our guides on reading a COA and net content versus HPLC purity.
Frequently asked questions
What does tandem mass spectrometry tell you that a single mass does not? The order of the amino acids. A single mass gives total composition, but many sequences share one mass; fragmentation reveals the actual order.
What are b and y ions? The two most common backbone fragment types in collision-induced dissociation. b ions keep the charge on the N-terminal part of the peptide, y ions on the C-terminal part. Matched b and y series let you read the sequence from both ends.
Can tandem MS tell leucine from isoleucine? Not with ordinary collision-induced dissociation, because the two residues have identical masses. Specialised fragmentation methods are needed to separate them.
Related reading
- Peptide COA Explained
- HPLC vs Mass Spectrometry: Peptide Purity Testing
- Amino Acid Analysis for Research Peptides
- Peptide Net Content vs HPLC Purity
References
- Hunt DF, Yates JR 3rd, Shabanowitz J, Winston S, Hauer CR. Protein sequencing by tandem mass spectrometry. Proceedings of the National Academy of Sciences USA. 1986;83(17):6233-6237. doi:10.1073/pnas.83.17.6233.
- Roepstorff P, Fohlman J. Proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biomedical Mass Spectrometry. 1984;11(11):601. doi:10.1002/bms.1200111109.
- Biemann K. Contributions of mass spectrometry to peptide and protein structure. Biomedical and Environmental Mass Spectrometry. 1988;16(1-12):99-111. doi:10.1002/bms.1200160119.
- Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science. 1989;246(4926):64-71. doi:10.1126/science.2675315.
- Eng JK, McCormack AL, Yates JR. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. Journal of the American Society for Mass Spectrometry. 1994;5(11):976-989. doi:10.1016/1044-0305(94)80016-2.
- Steen H, Mann M. The ABC's (and XYZ's) of peptide sequencing. Nature Reviews Molecular Cell Biology. 2004;5(9):699-711. doi:10.1038/nrm1468.
Research use only. All products sold by Morpheus Research are intended strictly for laboratory research and are not for human or veterinary consumption. Nothing in this article is medical advice, and no statement here is intended to diagnose, treat, cure or prevent any condition. Study findings are reported as published and should not be read as evidence of effects in people.